INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
INOVIO (INO) announced plans to submit a BLA for INO-3107 as a potential treatment for Recurrent Respiratory Papillomatosis in the second half of 2024. This followed an Initial Comprehensive Multidisciplinary Breakthrough Therapy Meeting with the FDA on critical aspects of the data package required to submit a BLA under the accelerated approval program.
At ESGCT, Precigen Data Supports Its Lead Candidate as RRP Treatment genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
PLYMOUTH MEETING - INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious.